Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/xifaxanr-rifaximin-treatment-following-overt-hepatic-encephalopathy-o-1023754
17 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/us-district-court-grants-summary-judgment-in-favor-of-fda-salix-and-t-1016430
10 Feb 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-announces-2025-salix-gastrointestinal-health-scholars-pr-981885
05 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/949208/bausch-health-and-salix-in-collaboration-with-health-organizations-recognize-the-second-annual-opioid-induced-constipation-oic-awareness-day
18 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943495/bausch-health-and-salix-to-present-at-the-american-association-for-the-study-of-liver-disease-aasld-the-red-c-phase-3-study-design-for-a-new-investigational-product-designed-to-address-serious-complications-of-cirrhosis
27 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/935601/acg-presidential-plenary-to-highlight-analysis-of-xifaxan-rifaximin-risk-reduction-of-overt-hepatic-encephalopathy-ohe-recurrence
Inspections and registrations
ABOUT THIS PAGE